Home » Topics » Disease categories and therapies » Endocrine/metabolic

Endocrine/metabolic
RSS

Genetics Institute reports new bone morphogenic protein

Jan. 14, 1997

Thomae reports agents for hypercholesterolemia

Jan. 14, 1997

Positive phase III results reported for SCF

Jan. 13, 1997

Millennium/Roche obesity collaboration results in another significant discovery

Jan. 13, 1997

New approach to obesity gene research at Lilly

Jan. 13, 1997

Pramlintide can be mixed with insulin

Jan. 10, 1997

Sugen reports efficacy of novel antidiabetic drugs at H&Q conference

Jan. 10, 1997

Harvard Scientific to present impotence abstract

Jan. 10, 1997

New insights into melanocortin role in obesity

Jan. 9, 1997

GeneMedicine to begin phase I testing of IGF-I Gene Medicine

Jan. 9, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 20, 2026.
ALN-5288 lowers tau levels in preclinical models
BioWorld Science
Pathological tau accumulation is a key driver of neurodegeneration in Alzheimer’s disease (AD) and other tauopathies such as progressive supranuclear palsy....
Capital remains selective in ‘barbell’ biotech market
BioWorld
Signs of recovery are emerging in the biotechnology investment sector, although investors across Asia say that capital is flowing selectively to companies that...
Dual FAAH/MAGL inhibition targets Alzheimer’s disease hyperexcitability
BioWorld Science
Reduced endocannabinoid signaling has been linked to neuronal hyperexcitability in Alzheimer’s disease (AD), suggesting that dual inhibition of fatty acid amide...
PSB-229 reduces plaque burden in Alzheimer’s models
BioWorld Science
Pyroglutamate-modified amyloid-β (pE3-Aβ) is a highly pathogenic Aβ species that accumulates within amyloid plaques and contributes to aggregation,...